ASPC 2018 Congress on CVD Prevention

 

ASPC 2018 Congress on CVD Prevention

SESSION 3 - Cardiometabolic Discussion

By ASPC 2018 Congress on CVD Prevention
By ASPC 2018 Congress on CVD Prevention
23 views
August 10, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

13:03
Novartis Cardiology

Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a R…

Feat. M. Koren

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

SESSION 3 - Cardiometabolic
28:08

Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a…

ASPC 2018 Congress on CVD Prevention

M. Kosiborod

978 views
24:44

Comprehensive Approach to Lowering CVD Risk in Diabetics

ASPC 2018 Congress on CVD Prevention

Y. Handelsman

779 views
23:46

Differentiating Antiplatelet Agents

ASPC 2018 Congress on CVD Prevention

P. Toth

626 views
18:12

SESSION 3 - Cardiometabolic Discussion

ASPC 2018 Congress on CVD Prevention

23 views